The background image is Illustration of a head opening up with gears inside
Seventh Annual Penn State Addiction Symposium is Dec. 6
The virtual event will highlight substance use research, treatment, education and community engagement from all Penn State campuses and Penn State Addiction Center for Translation community partners on Monday, Dec. 6, from 9 a.m. to 3 p.m.
Continuing Education credits (AMA and APA) are available.
Agenda
Keynote speakers
Participants are eligible to receive one credit hour for each keynote address. Credit hours will be awarded based on attendance. Participants can choose to attend one or both keynote addresses.
Judith Feinberg, MD
Judith Feinberg, MD
Vice Chair, Research and Professor, Infectious Diseases
West Virginia UniversityIn 2005, Dr. Judith Feinberg was the first physician in metropolitan Cincinnati to recognize that opioid injection drug use had emerged as a health threat due to increased endocarditis admissions. She became involved in harm reduction efforts and, in 2014, after a nine-year effort, she established Ohio’s third syringe exchange and its first true syringe services program, the Cincinnati Exchange Project.
West Virginia has the highest rates of acute hepatitis B, acute hepatitis C, Neonatal Abstinence Syndrome, and overdose deaths in the U.S. After a long career in HIV/AIDS, Feinberg came to WVU in late 2015 to focus on ending these opioid-related epidemics at their epicenter. As Professor of Behavioral Medicine & Psychiatry and Professor of Medicine/Infectious Diseases, she is working hard to turn the tide on the opioid-related epidemics.
Feinberg has federal funding from state and federal agencies and was recently named the first E.B. Flink Vice Chair for Research in the Department of Medicine.
Jane Liebschutz, MD, MPH, FACP
Jane Liebschutz, MD, MPH, FACP
Chief, Division of General Internal Medicine
University of PittsburghDr. Jane Liebschutz’s research is focused on developing interventions to combat the current crisis in opioid use disorders. More broadly, her research focuses on substance use, violence and mental health within the practice of general medical care.
Liebschutz has conducted numerous observation and intervention studies, including research on opioid prescribing for chronic pain in primary care. She has also directed randomized trials to study the treatment of opioid and injection drug use disorders in hospitalized patients. Liebschutz has a sustained history of funding from local, state and federal sources.
Liebschutz is a primary care doctor who also practices addiction medicine, having cared for hundreds of patients with substance use disorder. Her clinical practice has focused on underserved populations, especially those who have experienced the triad of trauma, pain and substance use.
Vice Chair, Research and Professor, Infectious Diseases
West Virginia University
In 2005, Dr. Judith Feinberg was the first physician in metropolitan Cincinnati to recognize that opioid injection drug use had emerged as a health threat due to increased endocarditis admissions. She became involved in harm reduction efforts and, in 2014, after a nine-year effort, she established Ohio’s third syringe exchange and its first true syringe services program, the Cincinnati Exchange Project.
West Virginia has the highest rates of acute hepatitis B, acute hepatitis C, Neonatal Abstinence Syndrome, and overdose deaths in the U.S. After a long career in HIV/AIDS, Feinberg came to WVU in late 2015 to focus on ending these opioid-related epidemics at their epicenter. As Professor of Behavioral Medicine & Psychiatry and Professor of Medicine/Infectious Diseases, she is working hard to turn the tide on the opioid-related epidemics.
Feinberg has federal funding from state and federal agencies and was recently named the first E.B. Flink Vice Chair for Research in the Department of Medicine.
Chief, Division of General Internal Medicine
University of Pittsburgh
Dr. Jane Liebschutz’s research is focused on developing interventions to combat the current crisis in opioid use disorders. More broadly, her research focuses on substance use, violence and mental health within the practice of general medical care.
Liebschutz has conducted numerous observation and intervention studies, including research on opioid prescribing for chronic pain in primary care. She has also directed randomized trials to study the treatment of opioid and injection drug use disorders in hospitalized patients. Liebschutz has a sustained history of funding from local, state and federal sources.
Liebschutz is a primary care doctor who also practices addiction medicine, having cared for hundreds of patients with substance use disorder. Her clinical practice has focused on underserved populations, especially those who have experienced the triad of trauma, pain and substance use.
Objectives
Upon completion, participants should be able to:
- Describe the impact of the opioid epidemic on the US and West Virginia: overdose fatalities, infectious and social consequences.
- Describe the key forces behind the ‘21st century’ opioid problem in West Virginia, Appalachia and rural America.
- Institute routine, universal opt-out screening for HIV per CDC guidelines, and offer HIV pre-exposure prophylaxis (PrEP) to those at high risk
- Identify pros and cons for collaborative care in opioid prescribing.
- Explain the use of algorithms when managing patients with aberrant behavior.
- Describe how and when to institute opioid agonist treatment with methadone or buprenorphine for patients with chronic pain and substance use disorder.
AMA
Penn State College of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses Using AMA Credit
Nurses will receive a certificate from Penn State College of Medicine verifying their participation in 2 hours of approved continuing medical education. Continuing education activities that are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing at: https://ce.med.psu.edu/nurse-credits.
APA
Penn State College of Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Penn State College of Medicine, Department of Psychiatry, is approved by the American Psychological Association to sponsor continuing education for psychologists. Penn State College of Medicine, Department of Psychiatry, maintains responsibility for this program and its content. Full attendance at the sessions and evaluation of each individual session attended is required to receive CE credit for psychologists. Partial credit will not be awarded. Late arrivals or early departures will preclude awarding of CE credits.
CME
Sign-in is required to receive CME credit. To receive the code, please register for the symposium here. All attendees will receive a link to a password-protected website where the code will be provided. For information specific to continuing medical education credit, call Continuing Education, at 717-531-6483 or email ContinuingEd@pennstatehealth.psu.edu.
The background image is Penn State Health Milton S. Hershey Medical Center's campus in Hershey, PA, is seen from the air.